The Aura Strategy Logo
The Aura Strategy Logo

What is CJC-1295?

Research Focus: Longevity, Muscle, GH

Benefits, Research & Legality (2025 Guide)

CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH). It is a Growth Hormone Secretagogue (GHS) designed to stimulate the pituitary gland to release more endogenous Growth Hormone (GH).

At a Glance

CJC-1295 is often modified with Drug Affinity Complex (DAC) technology, which allows it to bind to plasma proteins, significantly extending its half-life and allowing for less frequent dosing. This section provides a general overview of its research context.

About CJC-1295

CJC-1295 is often modified with Drug Affinity Complex (DAC) technology, which allows it to bind to plasma proteins, significantly extending its half-life and allowing for less frequent dosing.

How It Works

Pituitary Stimulation

Binds to GHRH receptors in the pituitary gland, triggering a pulsatile release of GH.

Increased GH and IGF-1

Leads to elevated levels of both GH and Insulin-like Growth Factor 1 (IGF-1), which mediate muscle growth, fat loss, and cellular repair.

Current Research Insights

Sustained GH Release

The DAC modification is highly valued in research for providing a sustained, physiological release of GH, avoiding the sharp peaks associated with other secretagogues.

Areas of Study

Muscle Mass and Strength

Investigated for promoting lean body mass and physical performance.

Anti-Aging and Longevity

Studied for improving body composition, bone density, and overall vitality associated with aging.

Research Use Only Section

CJC-1295 is strictly intended for laboratory and clinical research:

  • Available exclusively from authorized research suppliers
  • Not FDA-approved for general therapeutic use
  • Comprehensive safety, efficacy, and dosage guidelines remain under ongoing investigation

FAQs

Research

  • Studies on GHRH analogs and their pharmacokinetics, particularly the DAC modification.
  • Research into the effects of sustained GH elevation on body composition and metabolism.

(The above references are representative and support the research context of this peptide, GLP hormone or regenerative therapy. All claims are for research purposes only and do not imply approved medical use.)